0001493152-22-017378.txt : 20220621
0001493152-22-017378.hdr.sgml : 20220621
20220621161550
ACCESSION NUMBER: 0001493152-22-017378
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220617
FILED AS OF DATE: 20220621
DATE AS OF CHANGE: 20220621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bowman Shawn M.
CENTRAL INDEX KEY: 0001799604
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39678
FILM NUMBER: 221028301
MAIL ADDRESS:
STREET 1: 1200 SUMMIT AVE
STREET 2: SUITE 414
CITY: FORT WORTH
STATE: TX
ZIP: 76102
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sanara MedTech Inc.
CENTRAL INDEX KEY: 0000714256
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 592220004
STATE OF INCORPORATION: TX
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1200 SUMMIT AVE
STREET 2: SUITE 414
CITY: FORT WORTH
STATE: TX
ZIP: 76102
BUSINESS PHONE: 817-529-2300
MAIL ADDRESS:
STREET 1: 1200 SUMMIT AVE
STREET 2: SUITE 414
CITY: FORT WORTH
STATE: TX
ZIP: 76102
FORMER COMPANY:
FORMER CONFORMED NAME: WOUND MANAGEMENT TECHNOLOGIES, INC.
DATE OF NAME CHANGE: 20080611
FORMER COMPANY:
FORMER CONFORMED NAME: MB SOFTWARE CORP
DATE OF NAME CHANGE: 19960805
FORMER COMPANY:
FORMER CONFORMED NAME: INAV TRAVEL CORPORATION
DATE OF NAME CHANGE: 19920703
4
1
ownership.xml
X0306
4
2022-06-17
0
0000714256
Sanara MedTech Inc.
SMTI
0001799604
Bowman Shawn M.
1200 SUMMIT AVE
SUITE 414
FORT WORTH
TX
76102
0
1
0
0
Pres. - Strategic Partnerships
Common Stock
2022-06-17
4
S
0
1000
20.02
D
19550
D
The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2022.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.50, inclusive. The reporting person undertakes to provide to Sanara MedTech Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
/s/ Shawn M. Bowman
2022-06-21